OYONO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

OYONO Trademark

Serial Number: 79318194 • Registration: 7002502

OYONO is a trademark filed by Maria Clementine Martin Klosterfrau Vertriebsgesellschaft m.b.H. on July 14, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Maria Clementine Martin Klosterfrau Vertriebsgesellschaft m.b.H. (4 trademarks)

Gereonsmühlengasse 1/11

Entity Type: 99

Trademark Details

Filing Date

July 14, 2021

Registration Date

March 21, 2023

Published for Opposition

January 3, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 26, 2023 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Jun 28, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Jun 28, 2023 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 21, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 21, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 13, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 25, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 25, 2023 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2022 TROA
REFUSAL PROCESSED BY IB
Jun 6, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 19, 2022 RFCS
REFUSAL PROCESSED BY MPU
May 19, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 12, 2022 RFCR
NON-FINAL ACTION WRITTEN
Apr 11, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 4, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 24, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 19, 2021 REPR